ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
Tax period
2016-01-01 to 2016-12-31
Filed
2017-04-18
IRS object ID
201711099349300741
Schema version
2016v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-04-18T00:00:00-05:00ReturnTs
Tax Period End2016-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN042088368PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GRAY GRAY & GRAY LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1150 ROYALL STREET SUITE 102AddressLine1Txt
CityCANTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02021ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN522396428EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1ALZHEIMER'S DISEASE RESEARCH FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlALZHBusinessNameControlTxt
Phone7812373800PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line134 WASHINGTON ST NO 200AddressLine1Txt
CityWELLESLEY HILLSCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02481ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonTIMOTHY W ARMOURPersonNm
Person TitlePRESIDENTPersonTitleTxt
Phone7812373800PhoneNum
Signature2017-04-10SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonRICHARD D TARDIFFPreparerPersonNm
PTINP00154902PTIN
Phone7814070300PhoneNum
Preparation2017-04-06PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address50.234.152.46IPv4AddressTxt
FieldValueIRS element (for citing)
IP2017-04-10IPDt
IP Tm10:37:12IPTm
IP TimezoneEDIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdFE63424659D3925972608316E315838AD83887F2AtSubmissionCreationDeviceId
At Submission Filing Device Id4CB60F71B332EFE142C1B35711A0205FB6B82728AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1CURE ALZHEIMER'S FUNDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerTIMOTHY W ARMOURPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line134 WASHINGTON STREETAddressLine1Txt
CityWELLESLEY HILLSCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02493ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$20,070,730GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.CUREALZ.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2004FormationYr
Legal Domicile StatePALegalDomicileStateCd
Activity Or MissionTO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTRHOPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body8VotingMembersGoverningBodyCnt
Voting Members Independent7VotingMembersIndependentCnt
Total Employee17TotalEmployeeCnt
Total Volunteers42TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$11,248,214PYContributionsGrantsAmt
CY Contributions Grants$16,220,862CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income-$3,438PYInvestmentIncomeAmt
CY Investment Income-$63,796CYInvestmentIncomeAmt
PY Other Revenue$3,150PYOtherRevenueAmt
CY Other Revenue$90CYOtherRevenueAmt
PY Total Revenue$11,247,926PYTotalRevenueAmt
CY Total Revenue$16,157,156CYTotalRevenueAmt
PY Grants And Similar Paid$9,717,746PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$12,429,812CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,026,369PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,298,940CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$662,484CYTotalFundraisingExpenseAmt
PY Other Expenses$2,296,583PYOtherExpensesAmt
CY Other Expenses$2,786,682CYOtherExpensesAmt
PY Total Expenses$13,040,698PYTotalExpensesAmt
CY Total Expenses$16,515,434CYTotalExpensesAmt
PY Revenues Less Expenses-$1,792,772PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$358,278CYRevenuesLessExpensesAmt
Total Assets BOY$12,424,725TotalAssetsBOYAmt
Total Assets EOY$12,463,210TotalAssetsEOYAmt
Total Liabilities BOY$166,819TotalLiabilitiesBOYAmt
Total Liabilities EOY$563,695TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$12,257,906NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$11,899,515NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionFUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$13,455,939ExpenseAmt
Grant$12,429,812GrantAmt
DescIN 2016, CURE ALZHEIMER'S FUND SUPPORTED 56 RESEARCH PROJECTS AT 32 LEADING RESEARCH INSTITUTIONS, FOR A FUNDING TOTAL OF MORE THAN $13 MILLION. THE MAJORITY OF PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,676,977ExpenseAmt
DescSUPPORT OF THE GRANTING PROCESS AND CREATING AWARENESS FOR THE NEED FOR MORE RESEARCH TOOK THE FORM OF MEETINGS OF THE RESEARCH CONSORTIUM TO REVIEW AND MODIFY CURE ALZHEIMER'S FUND'S RESEARCH AGENDA, SUPPORT OF THE SCIENTIFIC ADVISORY BOARD IN REVIEWING PROPOSALS AND MEETINGS, MAILINGS AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$11,679ExpenseAmt
DescCURE ALZHEIMER'S FUND SERVES AS FIDUCIARY AGENT FOR A SERIES OF INDEPENDENTLY PRODUCED VIDEOS ABOUT ALZHEIMER'S DISEASE. WITH AN EXECUTIVE PRODUCER, THE ORGANIZATION RECEIVES FUNDS FROM THE METROPOLITAN LIFE FOUNDATION, DISPENSES THEM AS APPROVED BY THE EXECUTIVE PRODUCER AND REPORTS THE FINANCIAL ACTIVITY PERIODICALLY TO THE METROPOLITAN LIFE FOUNDATION.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
DescCURE ALZHEIMER'S FUND SERVES AS FIDUCIARY AGENT FOR A SERIES OF INDEPENDENTLY PRODUCED VIDEOS ABOUT ALZHEIMER'S DISEASE. WITH AN EXECUTIVE PRODUCER, THE ORGANIZATION RECEIVES FUNDS FROM THE METROPOLITAN LIFE FOUNDATION, DISPENSES THEM AS APPROVED BY THE EXECUTIVE PRODUCER AND REPORTS THE FINANCIAL ACTIVITY PERIODICALLY TO THE METROPOLITAN LIFE FOUNDATIONDesc
FieldValueIRS element (for citing)
Total Program Service Expenses$15,144,595TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document20IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee17EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members8GoverningBodyVotingMembersCnt
Independent Voting Member7IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonTIMOTHY W ARMOURPersonNm
Phone7812373800PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line134 WASHINGTON STREET STE 200AddressLine1Txt
CityWELLESLEY HILLSCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02481ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (12 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeInd
JEFFREY MORBY
CO-CHAIRMAN OF BOARD20.00Yes (X)$0$0$0
JACQUELINE MORBY
DIRECTOR5.00Yes (X)$0$0$0
HENRY MCCANCE
CO-CHAIRMAN OF BOARD5.00Yes (X)$0$0$0
PHYLLIS RAPPAPORT
DIRECTOR2.00Yes (X)$0$0$0
ROBERT GREENHILL
DIRECTOR2.00Yes (X)$0$0$0
TIMOTHY W ARMOUR
PRESIDENT & CEO40.00Yes (X)$216,933$0$0Yes (X)
MATTHEW SZULIK
TREASURER2.00Yes (X)$0$0$0Yes (X)
SHERRY SHARP
DIRECTOR2.00Yes (X)$0$0$0
MARGARET SMITH
SECRETARY & SR VICE PRESIDENT20.00$112,942$0$0Yes (X)
JOHN SLATTERY
SENIOR VICE PRESIDENT40.00$161,462$0$0Yes (X)
SALLY G ROSENFIELD
SENIOR VICE PRESIDENT40.00$164,984$0$8,200Yes (X)
BARBARA CHAMBERS
SENIOR ENGMT OFFICER, MARKETING & COMMUNICATIONS40.00$161,462$0$8,600Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$817,783TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$16,800TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K5IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (4 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
GRYPHON CONSULTING LLC
21 DEAN STBELMONTMA02478FINANACIAL AND MANAGEMENT CONSULTING$174,667
O'NEIL & ASSOCIATES
31 NEW CHARDON STBOSTONMA02114PUBLIC RELATIONS CONSULTING$130,000
DAVID SHENK
216 ST JOHNS PLACE APT DBROOKLYNNY11217PROGRAM AND FUNDRAISING CONSULTING$120,000
ALTSHULERSTAATS LLC
61 DEAN ROADBROOKLINEMA02445MANAGEMENT CONSULTING$112,500
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K4CntrctRcvdGreaterThan100KCnt
All Other Contributions$16,220,862AllOtherContributionsAmt
Noncash Contributions$3,928,416NoncashContributionsAmt
Total Contributions$16,220,862TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$611TotalRevenueColumnAmt
Exclusion$611ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$3,849,167SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$3,913,574SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$64,407SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$64,407TotalRevenueColumnAmt
Related Or Exempt Func Income-$64,407RelatedOrExemptFuncIncomeAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHER INCOMEDesc
Business900099BusinessCd
Total Revenue Column$90TotalRevenueColumnAmt
Related Or Exempt Func Income$90RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Other Revenue Total$90OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$16,157,156TotalRevenueColumnAmt
Related Or Exempt Func Income-$64,317RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$611ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$12,429,812TotalAmt
Program Services$12,429,812ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$834,583TotalAmt
Program Services$559,583ProgramServicesAmt
Management And General$102,470ManagementAndGeneralAmt
Fundraising$172,530FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$331,524TotalAmt
Program Services$108,122ProgramServicesAmt
Management And General$82,259ManagementAndGeneralAmt
Fundraising$141,143FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$32,482TotalAmt
Program Services$20,940ProgramServicesAmt
Management And General$4,321ManagementAndGeneralAmt
Fundraising$7,221FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$25,051TotalAmt
Program Services$8,830ProgramServicesAmt
Management And General$6,732ManagementAndGeneralAmt
Fundraising$9,489FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$75,300TotalAmt
Program Services$42,921ProgramServicesAmt
Management And General$12,048ManagementAndGeneralAmt
Fundraising$20,331FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$31,286TotalAmt
Management And General$31,286ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$141,583TotalAmt
Management And General$141,583ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$367,351TotalAmt
Program Services$164,000ProgramServicesAmt
Management And General$176,851ManagementAndGeneralAmt
Fundraising$26,500FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$48,027TotalAmt
Program Services$6,701ProgramServicesAmt
Fundraising$41,326FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$16,598TotalAmt
Management And General$15,771ManagementAndGeneralAmt
Fundraising$827FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$87,285TotalAmt
Program Services$49,752ProgramServicesAmt
Management And General$13,966ManagementAndGeneralAmt
Fundraising$23,567FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$144,141TotalAmt
Program Services$106,876ProgramServicesAmt
Management And General$15,729ManagementAndGeneralAmt
Fundraising$21,536FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,700TotalAmt
Program Services$1,575ProgramServicesAmt
Fundraising$125FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$7,034TotalAmt
Management And General$7,034ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$3,950TotalAmt
Management And General$3,950ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
RESEARCH EXPENSES$1,027,182$1,027,182
PUBLIC RELATIONS$144,070$144,070
POSTAGE AND SHIPPING$127,298$94,244$5,742$27,312
PRINTING AND REPRODUCTI$107,129$77,757$2,910$26,462

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$532,048TotalAmt
Program Services$302,230ProgramServicesAmt
Management And General$85,703ManagementAndGeneralAmt
Fundraising$144,115FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$16,515,434TotalAmt
Program Services$15,144,595ProgramServicesAmt
Management And General$708,355ManagementAndGeneralAmt
Fundraising$662,484FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$2,717,780BOYAmt
EOY$2,792,710EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$7,411,840BOYAmt
EOY$6,371,310EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$2,231,768BOYAmt
EOY$3,097,825EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$45,948BOYAmt
EOY$141,354EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$66,173LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$15,264LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$8,392BOYAmt
EOY$50,909EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$8,997BOYAmt
EOY$9,102EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$12,424,725BOYAmt
EOY$12,463,210EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$91,251BOYAmt
EOY$260,603EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$75,568BOYAmt
EOY$303,092EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$166,819BOYAmt
EOY$563,695EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$10,224,238BOYAmt
EOY$8,710,240EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,033,668BOYAmt
EOY$3,189,275EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$12,257,906BOYAmt
EOY$11,899,515EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$12,424,725BOYAmt
EOY$12,463,210EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$358,278ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$113NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$9,103,453CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6,388,347CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,640,759CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$11,248,214CurrentTaxYearMinus1YearAmt
Current Tax Year$16,220,862CurrentTaxYearAmt
Total$55,601,635TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$9,103,453CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6,388,347CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,640,759CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$11,248,214CurrentTaxYearMinus1YearAmt
Current Tax Year$16,220,862CurrentTaxYearAmt
Total$55,601,635TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$10,743,423SubstantialContributorsTotAmt
Public Support Total170$44,858,212PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,166CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years-$15,933CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$11,420CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year-$3,438CurrentTaxYearMinus1YearAmt
Current Tax Year-$63,796CurrentTaxYearAmt
Total-$60,581TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$13,447CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$10,000CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus1 Year$3,150CurrentTaxYearMinus1YearAmt
Current Tax Year$90CurrentTaxYearAmt
Total$26,687TotalAmt
FieldValueIRS element (for citing)
Total Support$55,567,741TotalSupportAmt
Public Support CY1700.80730PublicSupportCY170Pct
Public Support PY1700.75850PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Volunteers0VolunteersInd
Paid Staff Or Management0PaidStaffOrManagementInd
Media Advertisements0MediaAdvertisementsInd
Mailings Members0MailingsMembersInd
Publications Or Broadcast0PublicationsOrBroadcastInd
Grants Other Organizations0GrantsOtherOrganizationsInd
Direct Contact LegislatorsYes (1)DirectContactLegislatorsInd
Direct Contact Legislators$75,376DirectContactLegislatorsAmt
Rallies Demonstrations0RalliesDemonstrationsInd
Other Activities0OtherActivitiesInd
Total Lobbying Expenditures$75,376TotalLobbyingExpendituresAmt
Not Described Section501c30NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART II-B, LINE 1:FormAndLineReferenceDesc
ExplanationPART II-B, LINE 1(I), OTHER LOBBYING ACTIVITIES: A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT.ExplanationTxt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$9,939OtherCostOrOtherBasisAmt
Depreciation$1,344DepreciationAmt
Book Value$8,595BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$56,234OtherCostOrOtherBasisAmt
Depreciation$13,920DepreciationAmt
Book Value$42,314BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$50,909TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescACCRUED EXPENSESDesc
Amt$303,092Amt
FieldValueIRS element (for citing)
Total Liability$303,092TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$16,170,809TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$113NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$13,766DonatedServicesAndUseFcltsAmt
Revenue Not Reported$13,653RevenueNotReportedAmt
Revenue Subtotal$16,157,156RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$16,157,156TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$16,529,200TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$13,766DonatedServicesUseFcltsAmt
Expenses Not Reported$13,766ExpensesNotReportedAmt
Expenses Subtotal$16,515,434ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$16,515,434TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationCUREALZ WAS DETERMINED TO BE EXEMPT FROM FEDERAL INCOME TAX UNDER PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986 (IRC) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION AS DEFINED IN SECTION 509(A)(3) OF THE IRC. ACCORDINGLY, NO PROVISIONS FOR FEDERAL OR STATE INCOME TAXES ARE REQUIRED. CUREALZ IS REQUIRED TO RECOGNIZE THE FINANCIAL STATEMENT IMPACT OF A TAX POSITION WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION. ANY INTEREST AND PENALTIES RECOGNIZED ASSOCIATED WITH A TAX POSITION WOULD BE CLASSIFIED AS CURRENT IN CUREALZ'S FINANCIAL STATEMENTS. CURRENTLY, THE TAX YEARS ENDED DECEMBER 31, 2013, 2014, AND 2015 ARE OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE AND THE MASSACHUSETTS DEPARTMENT OF REVENUE. HOWEVER, CUREALZ IS NOT CURRENTLY UNDER AUDIT NOR HAS CUREALZ BEEN CONTACTED BY ANY OF THESE JURISDICTIONS. BASED ON THE EVALUATION OF CUREALZ'S TAX POSITIONS, MANAGEMENT BELIEVES ALL POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISION FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAS BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2016.ExplanationTxt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained0GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionEUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMRegionTxt
Type Of Activities ConductedGRANTS AWARDEDTypeOfActivitiesConductedTxt
Region Total Expenditures$724,908RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee0ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$724,908SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$724,908TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (4 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMTHERAPUTIC MODULATION OF TREM2 ACTIVITY.$150,000CHECK
EUROPE (INCLUDING ICELAND & GREENLAND)CIRCUITS: EPIGENETIC DETERMINANTS OF HUMAN COGNITIVE AGING$199,600CHECK
EUROPE (INCLUDING ICELAND & GREENLAND)CIRCUITS: UTILIZING FUNCTIONAL MAPS TO PRIORITIZE THERAPEUTIC TARGETS IN ALZHEIMER'S DISEASE$225,308CHECK
EUROPE (INCLUDING ICELAND & GREENLAND)NANOBODIES TO CROSS THE BLOOD-BRAIN BARRIER$150,000CHECK
FieldValueIRS element (for citing)
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE CHAIR OF THE RESEARCH CONSORTIUM (RC) AND SUITABLE MEMBERS OF THE RC AND SCIENTIFIC ADVISORY BOARD (SAB) REVIEW EACH PROPOSAL FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S. THE BOARD OF DIRECTORS OF CURE ALZHEIMER'S FUND PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY MEMBER OF THE RC, SAB OR EXECUTIVE COMMITTEE WILL BE RETURNED TO THE RESEARCHER FOR CLARIFICATION. SUCH QUESTIONS OR CONCERNS MAY RESULT IN MODIFICATION AND RESUBMISSION, OR, IN EXTREME CASES, REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTION, OR REJECTION. THERE IS NO "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION WHEN RESEARCHERS ARE NOTIFIED THAT A PROPOSAL WILL BE FUNDED.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (53 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
CARNEGIE MELLON UNIVERSITY
4400 FIFTH AVEPITTSBURGHPA15213501(C)(3)$189,610CIRCUITS: INTERPRETING ALZHEIMER'S DISEASE-ASSOCIATED GENETIC VARIATION AT ENHANCER REGIONS
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVEBOSTONMA02115501(C)(3)$150,000EARLY ROLE OF MICROGLIA IN SYNAPSE LOSS IN ALZHEIMER'S DISEASE
COLUMBIA UNIVERSITY
710 WEST 168TH STREET 3RD FLOORNEW YORKNY10032501(C)(3)$150,000INVESTIGATING THE MECHANISM OF ENTORHINAL CORTEX HYPERMETABOLISM IN APOE4 TARGETED REPLACEMENT MICE
DUKE UNIVERSITY SCHOOL OF MEDICINE
8 DUKE UNIVERSITY MEDICAL CENTERDURHAMNC27703501(C)(3)$151,655PATHWAY CROSS-TALKS ASSOCIATED WITH SEX AND RISK FOR ALZHEIMER'S DISEASEGREENSPACE
DUKE UNIVERSITY SCHOOL OF MEDICINE
8 DUKE UNIVERSITY MEDICAL CENTERDURHAMNC27703501(C)(3)$112,662THE APOE MIMETIC THERAPEUTIC PEPTIDE CN-105 ATTENUATES AD PATHOLOGY AND IMPROVES FUNCTIONAL OUTCOMES IN A MURINE MODEL OF ALZHEIMER'S DISEASEGREENSPACE
HARVARD
677 HUNTINGTON AVEBOSTONMA02115501(C)(3)$150,000GOLD ACTIVATION OF THE 26S PROTEASOME FOR THE TREATMENT OF ALZHEIMER'S DISEASE
HARVARD COLLEGE
677 HUNTINGTON AVEBOSTONMA02115501(C)(3)$250,000LAN ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAE L LEVY PLACENEW YORKNY10029501(C)(3)$150,000INTERSECTION OF MICROGLIAL TRANSCRIPTOMES TO IDENTIFY KEY ALZHEIMER'S PATHWAYS OF BRAIN PHAGOCYTES
JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVENEW YORKNY10065501(C)(3)$120,006INTERSECTIMAX REGULATION OF MICROGLIAL LYSOSOME ACIDIFICATION
MASSACHUSETTS GENERAL HOSPITAL
125 NASHUA STREETBOSTONMA02114501(C)(3)$150,000GAU ROLE OF NEUREXINS IN ALZHEIMER'S DISEASE PATHOPHYSIOLOGY
MASSACHUSETTS GENERAL HOSPITAL
125 NASHUA STREETBOSTONMA02114501(C)(3)$150,000EXTRACELLULAR VESICLE-BASED TARGETING OF CD33-MEDIATED PATHOLOGY FOR ALZHEIMER'S DISEASE THERAPY
MASSACHUSETTS GENERAL HOSPITAL
125 NASHUA STREETBOSTONMA02114501(C)(3)$145,004CIRCUITS: IPS CELLS AND THE HUMAN BRAIN
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVECAMBRIDGEMA021394307501(C)(3)$93,844ROLE OF THE BLOOD-BRAIN BARRIER IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVECAMBRIDGEMA021394307501(C)(3)$250,000STUDYING THE FUNCTIONAL CONSEQUENCES OF ALZHEIMER'S DISEASE RISK VARIANTS IN THE CLU AND ABCA7 GENES USING BOTH HUMAN AND MOUSE MODELS
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVECAMBRIDGEMA021394307501(C)(3)$400,000CIRCUITS: FUNCTIONAL ANALYSIS OF ALZHEIMER'S DISEASE RISK GENES USING HUMAN-INDUCED PLURIPOTENT STEM CELLS
METHODIST HOSPITAL
PO BOX 4384HOUSTONTX772104384501(C)(3)$150,000HIGH CONTENT DRUG SCREEN USING A NOVEL 3D CELL MODEL OF ALZHEIMER'S DISEASE
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$400,000MICROGLIAL CORE/CD33 AND ALZHEIMER'S DISEASE: FROM BIOLOGY TO THERAPY
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$200,000ROLE OF BLOOD-BRAIN BARRIER FUNCTION IN ALZHEIMER'S DISEASE PATHOGENESIS INVESTIGATED USING A 3D MICROFLUIDIC PLATFORM
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$400,0003D NEURAL CORE/HIGH-THROUGHPUT DRUG SCREENING FOR ALZHEIMER'S DISEASE USING 3D HUMAN NEURAL CELL CULTURE SYSTEMS
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$375,000ROT SEARCH FOR FEMALE-SPECIFIC FACTORS CONTRIBUTING TO RISK FOR ALZHEIMER'S DISEASE
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$175,000MOI. EXT AB EXPRESSION PROTECTS THE BRAIN FROM HERPES SIMPLEX VIRUS (EXTENSION)
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$1,500,000ALZHEIMER'S GENOME PROJECT
MGH GENETICS AND AGING
125 NASHUA STREETBOSTONMA02114501(C)(3)$173,750GENES TO THERAPIES
MGH RESEARCH FINANCE
PO BOX 414876BOSTONMA02114501(C)(3)$200,000SYSTEMIC INFLAMMATORY NETWORKS IN ALZHEIMER'S DISEASE
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
PO BOX V-38PALO ALTOCA94304501(C)(3)$150,000REJUVENATION OF MICROGLIA IN BRAIN AGING AND NEURODEGENERATION
REGENTS OF THE UNIVERSITY OF CALIFORNIA
300 LAKESIDE DRIVE 6TH FLOOROAKLANDCA94612501(C)(3)$125,000COMBINATION OF ANTI-AB & GROWTH FACTOR THERAPY
REGENTS OF THE UNIVERSITY OF CALIFORNIA
300 LAKESIDE DRIVE 6TH FLOOROAKLANDCA94612501(C)(3)$125,000IDENTIFICATION OF PROTECTIVE HUMAN IMMUNE RESPONSE FOR ALZHEIMER'S DISEASE
SALK INSTITUTE FOR BIOLOGICAL STUDIES
10010 N TORREY PINES ROADLA JOLLACA92037501(C)(3)$95,000CIRCUITS: WHOLE GENOME CHARACTERIZATION OF DNA METHYLATION CHANGES IN THE AGED AND ALZHEIMER'S DISEASE HUMAN BRAIN
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
10901 N TORREY PINES ROADLA JOLLACA92037501(C)(3)$150,000SORA ATTENUATES A TOXICITY THROUGH INTERACTIONS WITH EPHA4
STANFORD UNIVERSITY
3172 PORTER DRIVEPALO ALTOCA943041212501(C)(3)$150,000UNDERSTANDING REACTIVE ASTROCYTES AND THEIR ROLES IN ALZHEIMER'S DISEASE
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142501(C)(3)$750,000CIRCUITS: PRODUCTION CENTER FOR REFERENCE AND VARIATION GENE-REGULATORY MAPS
THE ROCKEFELLER UNIVERSITY
1230 YORK AVENUENEW YORKNY10065501(C)(3)$250,000UNCOVERING DETERMINANTS OF NEURONAL VULNERABILITY IN ALZHEIMER'S DISEASE
THE ROCKEFELLER UNIVERSITY
1230 YORK AVENUENEW YORKNY10065501(C)(3)$450,000DISCOVERY OF CK1 ACTIVATORS FOR INDUCING THE AUTOPHAGIC DEGRADATION OF APP BETA-CTF
THE TRUSTEES OF BOSTON UNIVERSITY
25 BUICK STREETBOSTONMA022151301501(C)(3)$150,000ALZHEIMER'S DISEASE DRUG DISCOVERY IN 3D
THE TRUSTEES OF BOSTON UNIVERSITY
25 BUICK STREETBOSTONMA022151301501(C)(3)$129,373DEVELOPMENT OF NOVEL APP DIMERIZATION INHIBITORS THAT LOWER AB LEVELS
THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVELA JOLLACA92093501(C)(3)$144,450ACCELERATION OF FDA REQUIRED GLP GENE TOXICITY STUDIES WITH THE GSM BPN-15606
THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVELA JOLLACA92093501(C)(3)$250,000ALZHEIMER DISEASE-ASSOCIATED MUTATIONS IN PROTEIN KINASE C
THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVELA JOLLACA92093501(C)(3)$194,950BINDING SITE CHARACTERIZATION OF A NOVEL PYRIDAZINE-DERIVED CLASS OF Y-SECRETASE MODULATORS
UNIVERSITY OF CHICAGO
947 E 58TH STREETCHICAGOIL60637501(C)(3)$250,000IN VITRO AND IN VIVO ANALYSIS OF APP S198P AND V675I VARIANTS
UNIVERSITY OF CHICAGO
947 E 58TH STREETCHICAGOIL60637501(C)(3)$250,000MECHANISMS BY WHICH THE GUT MICROBIOME INFLUENCES AMYLOID DEPOSITION AND NEUROINFLAMMATION IN MOUSE MODELS OF ALZHEIMER'S DISEASE
UNIVERSITY OF CHICAGO
947 E 58TH STREETCHICAGOIL60637501(C)(3)$150,000BIN1 IN ALZHEIMER'S DISEASE NEUROPATHOLOGY
UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE
9201 UNIVERSITY CITY BLVDCHARLOTTENC282230001501(C)(3)$150,0003DDS: A 3-D HUMAN NEURAL CELL CULTURE SYSTEM FOR STUDYING NEURON-MICROGLIA INTERACTION IN ALZHEIMER'S DISEASE
UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUEROCHESTERNY14642501(C)(3)$150,000WILL RESTORATION OF NORMAL GLYMPHATIC FUNCTION SLOW PROGRESSION OF COGNITIVE DECLINE AND AMYLOID PLAQUES IN A MURINE ALZHEIMER MODEL?
UNIVERSITY OF SOUTHERN CALIFORNIA
3720 FLOWER STREETLOS ANGELESCA900892821501(C)(3)$225,000PICALM GENE THERAPY AND DRUG SCREENING FOR ABETA CLEARANCE
UNIVERSITY OF SOUTHERN CALIFORNIA
3720 FLOWER STREETLOS ANGELESCA900892821501(C)(3)$150,000TARGETING BENEFICIAL INNATE IMMUNITY IN ALZHEIMER'S BY IRAK-M DELETION
UNIVERSITY OF VIRGINIA
PO BOX 400195CHARLOTTESVILLEVA229044195501(C)(3)$150,000THE ROLE OF MENINGEAL LYMPHATICS IN CLEANSING THE BRAIN: IMPLICATIONS FOR ALZHEIMER'S DISEASE
UNIVERSITY OF VIRGINIA
PO BOX 400195CHARLOTTESVILLEVA229044195501(C)(3)$100,000CELL CYCLE RE-ENTRY IN 3-D HUMAN NEURON CULTURES
WASHINGTON UNIVERSITY ST LOUIS
700 ROSEDALE AVEST LOUISMO631121408115(1)$150,000MODELING NEURONAL AGING IN SPECIFIC SUBTYPES OF HUMAN NEURONS BY MICRORNA-MEDIATED NEURONAL REPROGRAMMING
WASHINGTON UNIVERSITY ST LOUIS
700 ROSEDALE AVEST LOUISMO631121408115(1)$49,600CHARACTERIZATION OF HUMAN APOEFL/FL TARGETED GENE REPLACEMENT MICE
WASHINGTON UNIVERSITY ST LOUIS
700 ROSEDALE AVEST LOUISMO631121408115(1)$250,000THE BIOLOGICAL IMPACT OF TREM LOCUS MUTATIONS IN ALZHEIMER'S DISEASE
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
9 CAMBRIDGE CENTERCAMBRIDGEMA02142501(C)(3)$150,000MODELING DNA METHYLATION CHANGES IN ALZHEIMER'S DISEASE USING HUMAN-INDUCED PLURIPOTENT STEM CELLS
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH
9 CAMBRIDGE CENTERCAMBRIDGEMA02142501(C)(3)$155,000CIRCUITS: WHOLE GENOME CHARACTERIZATION OF DNA METHYLATION CHANGES IN THE AGED AND ALZHEIMER'S DISEASE HUMAN BRAIN
YALE UNIVERSITY
333 CEDAR STNEW HAVENCT06510501(C)(3)$75,000IMPACT OF INFLAMMASOME DEACTIVATION ON ALZHEIMER'S DISEASE

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE CHAIR OF THE RESEARCH CONSORTIUM (RC) AND SUITABLE MEMBERS OF THE RC AND SCIENTIFIC ADVISORY BOARD (SAB) REVIEW EACH PROPOSAL FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S. THE BOARD OF DIRECTORS OF CURE ALZHEIMER'S FUND PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY MEMBER OF THE RC, SAB OR EXECUTIVE COMMITTEE WILL BE RETURNED TO THE RESEARCHER FOR CLARIFICATION. SUCH QUESTIONS OR CONCERNS MAY RESULT IN MODIFICATION AND RESUBMISSION, OR, IN EXTREME CASES, REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTION, OR REJECTION. THERE IS NO "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION WHEN RESEARCHERS ARE NOTIFIED THAT A PROPOSAL WILL BE FUNDED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
TIMOTHY W ARMOUR
PRESIDENT & CEO$216,933$0$0$0$0$0$0$0$0$0$216,933$0$0$0
JOHN SLATTERY
SENIOR VICE PRESIDENT$161,462$0$0$0$0$0$0$0$0$0$161,462$0$0$0
SALLY G ROSENFIELD
SENIOR VICE PRESIDENT$164,984$0$0$0$0$0$0$0$8,200$0$173,184$0$0$0
BARBARA CHAMBERS
SENIOR ENGMT OFFICER, MARKETING & CO$161,462$0$0$0$0$0$0$0$8,600$0$170,062$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationA COMPENSATION COMMITTEE REVIEWS ALL COMPENSATION ANNUALLY.ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution70ContributionCnt
Noncash Contributions Rpt F990$3,902,516NoncashContributionsRptF990Amt
Method Of Determining RevenuesCLOSE OF BUSINESSMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (1)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 32B:FormAndLineReferenceDesc
ExplanationWHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR AS SOON THEREAFTER AS IS PRACTICAL THROUGH BANK OF NEW YORK/MELLON.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 2JEFFREY MORBY AND JACQUELINE MORBY ARE BOTH DIRECTORS AND SPOUSES.
FORM 990, PART VI, SECTION B, LINE 11BTHE PRESIDENT REVIEWS THE FORM 990 AND PROVIDES COPIES TO THE DIRECTORS BEFORE APPROVING THE FORM FOR SUBMISSION.
FORM 990, PART VI, SECTION B, LINE 12CTHE PRESIDENT REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH CONFLICTS OF INTEREST BY REQUESTING THAT ALL OFFICERS, DIRECTORS, AND FOUNDERS RADIFY AN ANNUAL STATEMENT DISCLOSING ALL INTERESTS THAT MIGHT CONFLICT WITH ANY INTEREST OF THE ORGANIZATION.
FORM 990, PART VI, SECTION B, LINE 15COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE PRESIDENT AND ALL OTHER EMPLOYEES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND AT THE ORGANIZATION'S WEBSITE.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.